| Item Type | Name |
|
Concept
|
Blood Pressure
|
|
Concept
|
Intracranial Aneurysm
|
|
Concept
|
Body Weight
|
|
Concept
|
Cosmids
|
|
Concept
|
Depressive Disorder, Major
|
|
Concept
|
Electron Transport Complex IV
|
|
Concept
|
Microtubule-Associated Proteins
|
|
Concept
|
Genes, MHC Class II
|
|
Concept
|
Glioblastoma
|
|
Concept
|
Obesity
|
|
Concept
|
Obesity, Morbid
|
|
Concept
|
Dyneins
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Markov Chains
|
|
Concept
|
Pyrophosphatases
|
|
Concept
|
Nerve Growth Factors
|
|
Concept
|
Poly I-C
|
|
Concept
|
Poly Adenosine Diphosphate Ribose
|
|
Concept
|
Probability
|
|
Concept
|
Protein Processing, Post-Translational
|
|
Concept
|
Frozen Sections
|
|
Concept
|
Risk Factors
|
|
Concept
|
Viral Core Proteins
|
|
Concept
|
Risk
|
|
Concept
|
Body Mass Index
|
|
Concept
|
Tomography, X-Ray Computed
|
|
Concept
|
Receptors, Vasopressin
|
|
Concept
|
Ultraviolet Rays
|
|
Concept
|
Vaccination
|
|
Concept
|
Neprilysin
|
|
Concept
|
Oligonucleotide Probes
|
|
Concept
|
HLA-C Antigens
|
|
Concept
|
Proportional Hazards Models
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Oligodeoxyribonucleotides, Antisense
|
|
Concept
|
NF-kappa B
|
|
Concept
|
Osteonectin
|
|
Concept
|
DNA, Antisense
|
|
Concept
|
DNA Probes
|
|
Concept
|
Immunotherapy, Active
|
|
Concept
|
In Situ Hybridization
|
|
Concept
|
Paraffin Embedding
|
|
Concept
|
Tissue Fixation
|
|
Concept
|
Paroxetine
|
|
Concept
|
DNA, Complementary
|
|
Concept
|
Waist-Hip Ratio
|
|
Concept
|
Body Fat Distribution
|
|
Concept
|
Brain-Derived Neurotrophic Factor
|
|
Concept
|
Cytochrome P-450 CYP2D6
|
|
Concept
|
Parkinson Disease
|
|
Concept
|
Paralysis, Hyperkalemic Periodic
|
|
Concept
|
In Situ Hybridization, Fluorescence
|
|
Concept
|
HMGB1 Protein
|
|
Concept
|
Microdissection
|
|
Concept
|
Positron-Emission Tomography
|
|
Concept
|
Receptor, Melanocortin, Type 4
|
|
Concept
|
Proteasome Endopeptidase Complex
|
|
Concept
|
Amino Acid Motifs
|
|
Concept
|
Potassium Channels, Inwardly Rectifying
|
|
Concept
|
Nephrolithiasis
|
|
Concept
|
CD11c Antigen
|
|
Concept
|
Spectrometry, Fluorescence
|
|
Concept
|
Chemokine CXCL2
|
|
Concept
|
Waist Circumference
|
|
Concept
|
Cathepsin H
|
|
Concept
|
MAP Kinase Kinase 6
|
|
Concept
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Logistic Models
|
|
Concept
|
Histone Deacetylase 1
|
|
Concept
|
RNA, Antisense
|
|
Concept
|
Tubulin
|
|
Concept
|
Patient Satisfaction
|
|
Concept
|
Minor Histocompatibility Antigens
|
|
Concept
|
Coronavirus Infections
|
|
Concept
|
Odds Ratio
|
|
Concept
|
Proto-Oncogene Proteins p21(ras)
|
|
Concept
|
Receptor, ErbB-2
|
|
Concept
|
Proliferating Cell Nuclear Antigen
|
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Receptors, Neurotensin
|
|
Concept
|
KCNQ1 Potassium Channel
|
|
Concept
|
Dynamins
|
|
Concept
|
Pandemics
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p27
|
|
Concept
|
Receptors, CCR6
|
|
Concept
|
Drug Eruptions
|
|
Concept
|
Neuroblastoma
|
|
Concept
|
Pneumonectomy
|
|
Concept
|
Staining and Labeling
|
|
Concept
|
Stevens-Johnson Syndrome
|
|
Concept
|
Oligonucleotides, Antisense
|
|
Concept
|
DNA Primers
|
|
Concept
|
Sendai virus
|
|
Concept
|
Fluorescence Resonance Energy Transfer
|
|
Concept
|
Overweight
|
|
Concept
|
Stathmin
|
|
Concept
|
Ubiquitination
|
|
Concept
|
HLA-A24 Antigen
|
|
Academic Article
|
Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer.
|
|
Academic Article
|
Third-generation oncolytic herpes simplex virus inhibits the growth of liver tumors in mice.
|
|
Concept
|
Enhancer of Zeste Homolog 2 Protein
|
|
Concept
|
Positron Emission Tomography Computed Tomography
|
|
Concept
|
Netrin-1
|
|
Concept
|
Citrullination
|
|
Concept
|
Polycomb Repressive Complex 2
|